Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218250 · ClinicalTrials.gov registry record · NA

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer

A NA study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
7
Study locations

NCT07218250: Recruiting NA study of Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT07218250 is a NA study of Breast Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 20 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07218250, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with breast cancer who are waiting to receive ongoing counseling services (outpatient psychotherapy services). The Single Counseling Session for Cancer-which I will refer to as the "study counseling" during this call-is a one-session, 60-minute counseling program designed to reduce anxiety and depression symptoms in people with cancer who are waiting to receive outpatient psychotherapy services. The researchers will look at whether the study counseling is effective in participants and practical (feasible) for them to complete.

Primary Outcome

Participants will complete a satisfaction survey after completing the SSC-C intervention. A 5-item, investigator- initiated, face-valid satisfaction survey will assess the degree with which participant found SSC-C helpful in developing an action plan to address their concerns, their perceived utility of the action plan, the degree with which they believe they will use the action plan, their motivation to do so, and the extent to which they will recommend SSC-C to other patients.

Conditions Studied

Interventions

  • BEHAVIORAL Single Counseling Session
  • OTHER American Cancer Society booklet

Study Locations (7)

New York

  • Memorial Sloan Kettering Suffolk- Commack (Consent Only) - Commack
  • Memorial Sloan Kettering Westchester (Consent Only) - Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
  • Memorial Sloan Kettering Nassau (Consent Only) - Uniondale

New Jersey

  • Memorial Sloan Kettering Basking Ridge (Consent Only) - Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
  • Memorial Sloan Kettering Bergen (Consent Only) - Montvale

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-10-15
Est. Completion 2026-10
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT07218250 shows while recruiting

NCT07218250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Single Counseling Session is the first listed.

NCT07218250 lists 7 locations in 2 states (New York, New Jersey).

Frequently Asked Questions

What is clinical trial NCT07218250 about?

NCT07218250 is a clinical study titled "A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer". The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with breast cancer who are waiting to receive ongoing counseling services (outpatient psychotherapy services). The Single Counseling Session for C...

What is the current status of trial NCT07218250?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-10-15. Estimated completion is 2026-10.

What conditions does trial NCT07218250 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT07218250?

The interventions under investigation include: Single Counseling Session (BEHAVIORAL), American Cancer Society booklet (OTHER).

Who is sponsoring clinical trial NCT07218250?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218250 being conducted?

This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07218250's enrollment target sits among peer trials

20 1079th of 1224 higher than 112 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07218250, the US trial registry maintained by the National Library of Medicine. NCT07218250 (small enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.